Ultragenyx Pharmaceutical RARE
NASDAQ RARE
$14.75 -0.28 (-1.86%)
At close: Oct 1, 2026 · 4:00 PM EDT

Ultragenyx Pharmaceutical (RARE) Minority Interest (2013 - 2026)

Updated

Ultragenyx Pharmaceutical's Minority Interest came in at $7 million for Q2 2026, unchanged from $7 million a year earlier and unchanged from the prior quarter.

Analysis

Ultragenyx Pharmaceutical (RARE) Minority Interest (2013 - 2026) Analysis & Trends

Going back to Q4 2013, Ultragenyx Pharmaceutical's Minority Interest data covers 9 quarters.

  • Going back by year, Minority Interest was $7 million in FY2024.
  • Business Quant data shows RARE's Minority Interest at $7 million (Q1 2026), $7 million (Q4 2025) and $7 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Ultragenyx Pharmaceutical 1.48 Bn -321.29 Mn 180.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.00 Mn
Mar 31, 2026 7.00 Mn
Dec 31, 2025 7.00 Mn
Sep 30, 2025 7.00 Mn
Jun 30, 2025 7.00 Mn
Mar 31, 2025 7.00 Mn
Dec 31, 2024 7.00 Mn
Sep 30, 2024 7.00 Mn
Dec 31, 2013 73.93 Mn
API Access

Ultragenyx Pharmaceutical Minority Interest API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=minority-interest&ticker=RARE&period=max&api_key=YOUR_API_KEY